NervGen Pharma Corp. (NGENF)
USD 2.12
(4.95%)
USD 2.12
(4.95%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | -145 Thousand CAD | -25.96% |
| 2022 | -115.11 Thousand CAD | -170.06% |
| 2021 | -42.62 Thousand CAD | -7.52% |
| 2020 | -39.64 Thousand CAD | -3.73% |
| 2019 | -38.22 Thousand CAD | -93.4% |
| 2018 | -19.76 Thousand CAD | 0.0% |
| 2017 | - CAD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | -38.3 Thousand CAD | 0.82% |
| 2024 Q2 | -15.02 Thousand CAD | 60.77% |
| 2023 Q2 | -34.99 Thousand CAD | -0.7% |
| 2023 Q1 | -34.75 Thousand CAD | 0.0% |
| 2023 FY | -145 Thousand CAD | -25.96% |
| 2023 Q3 | -36.62 Thousand CAD | -4.65% |
| 2023 Q4 | -38.62 Thousand CAD | -5.45% |
| 2022 FY | -115.11 Thousand CAD | -170.06% |
| 2022 Q4 | -34.75 Thousand CAD | -0.0% |
| 2022 Q3 | -34.75 Thousand CAD | -1.55% |
| 2022 Q2 | -34.22 Thousand CAD | -200.61% |
| 2022 Q1 | -11.38 Thousand CAD | -1.57% |
| 2021 Q2 | -10.57 Thousand CAD | -5.88% |
| 2021 Q1 | -9983.00 CAD | 0.0% |
| 2021 Q3 | -10.86 Thousand CAD | -2.8% |
| 2021 Q4 | -11.2 Thousand CAD | -3.15% |
| 2021 FY | -42.62 Thousand CAD | -7.52% |
| 2020 FY | -39.64 Thousand CAD | -3.73% |
| 2020 Q1 | - CAD | 0.0% |
| 2020 Q4 | - CAD | 0.0% |
| 2020 Q3 | - CAD | 0.0% |
| 2020 Q2 | - CAD | 0.0% |
| 2019 Q3 | - CAD | 0.0% |
| 2019 Q4 | - CAD | 0.0% |
| 2019 FY | -38.22 Thousand CAD | -93.4% |
| 2019 Q2 | - CAD | 0.0% |
| 2019 Q1 | - CAD | 0.0% |
| 2018 Q1 | - CAD | 0.0% |
| 2018 Q2 | - CAD | 0.0% |
| 2018 FY | -19.76 Thousand CAD | 0.0% |
| 2018 Q3 | - CAD | 0.0% |
| 2018 Q4 | - CAD | 0.0% |
| 2017 FY | - CAD | 0.0% |
| 2017 Q3 | - CAD | 0.0% |
| 2017 Q4 | - CAD | 0.0% |
| 2017 Q2 | - CAD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Capstone Therapeutics Corp. | 9.61 Million USD | 101.509% |
| Skye Bioscience, Inc. | -124.25 Thousand USD | -16.702% |
| Northwest Biotherapeutics, Inc. | -25.79 Million USD | 99.438% |
| Santhera Pharmaceuticals Holding AG | 119.1 Million USD | 100.122% |
| Nascent Biotech, Inc. | -319.5 Thousand USD | 54.617% |
| Qrons Inc. | - USD | Infinity% |
| ProtoKinetix, Incorporated | -48.25 Thousand USD | -200.468% |
| Adynxx, Inc. | - USD | Infinity% |
| Arch Therapeutics, Inc. | -2439.00 USD | -5845.182% |
| BioStem Technologies, Inc. | 15.42 Million USD | 100.94% |
| Regen BioPharma, Inc. | 176.56 Thousand USD | 182.127% |
| Evofem Biosciences, Inc. | 11.7 Million USD | 101.239% |
| Rebus Holdings, Inc. | - USD | Infinity% |
| Burzynski Research Institute, Inc. | - USD | Infinity% |
| Neon Bloom, Inc. | - USD | Infinity% |
| Acro Biomedical Co., Ltd. | 140.5 Thousand USD | 203.205% |
| Eiger BioPharmaceuticals, Inc. | 14.99 Million USD | 100.967% |
| Nanobac Pharmaceuticals, Incorporated | 3102.00 USD | 4774.5% |
| Institute of Biomedical Research Corp. | - USD | Infinity% |
| SQZ Biotechnologies Company | 9.79 Million USD | 101.481% |
| Intellipharmaceutics International Inc. | 65.72 Thousand USD | 320.611% |
| Propanc Biopharma, Inc. | -34.15 Thousand USD | -324.606% |
| Mesoblast Limited | -35.16 Million USD | 99.588% |
| Marizyme, Inc. | 457.7 Thousand USD | 131.681% |
| Genus plc | 178.7 Million USD | 100.081% |
| VioQuest Pharmaceuticals, Inc. | - USD | Infinity% |
| Pharming Group N.V. | 220.1 Million USD | 100.066% |
| Therapeutic Solutions International, Inc. | 62.22 Thousand USD | 333.026% |
| CNBX Pharmaceuticals Inc. | 410.16 Thousand USD | 135.352% |
| Nymox Pharmaceutical Corporation | -11 Thousand USD | -1218.209% |
| ContraFect Corporation | -154 Thousand USD | 5.842% |
| PsyBio Therapeutics Corp. | -50 Thousand USD | -190.006% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 76.76 Thousand USD | 288.902% |
| IMV Inc. | -962.29 Thousand USD | 84.932% |
| AXIM Biotechnologies, Inc. | -387.5 Thousand USD | 62.58% |
| MultiCell Technologies, Inc. | 49.32 USD | 294104.461% |
| ONE Bio Corp. | 20.12 Million USD | 100.72% |
| Accustem Sciences Inc. | - USD | Infinity% |
| RVL Pharmaceuticals plc | 40.26 Million USD | 100.36% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| EV Biologics, Inc. | 48.9 Thousand USD | 396.53% |
| Q BioMed Inc. | -8988.00 USD | -1513.296% |
| Emmaus Life Sciences, Inc. | 28.25 Million USD | 100.513% |
| Mosaic ImmunoEngineering Inc. | - USD | Infinity% |
| Biomind Labs Inc. | -15.42 Thousand USD | -840.113% |
| American Oriental Bioengineering, Inc. | 44.35 Million USD | 100.327% |
| Provectus Biopharmaceuticals, Inc. | -1.14 Million USD | 87.298% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Oncotelic Therapeutics, Inc. | 70 Thousand USD | 307.147% |
| GlobeStar Therapeutics Corporation | - USD | Infinity% |
| THC Farmaceuticals, Inc. | -4952.00 USD | -2828.17% |
| Curative Biotechnology, Inc. | -97.51 Thousand USD | -48.698% |
| GB Sciences, Inc. | -624.00 USD | -23137.66% |
| Alpha Cognition Inc. | -86.02 Thousand USD | -68.553% |
| HST Global, Inc. | - USD | Infinity% |
| CSL Limited | 7.56 Billion USD | 100.002% |
| Wesana Health Holdings Inc. | - USD | Infinity% |
| Halberd Corporation | -208.00 USD | -69612.981% |
| Enzolytics Inc. | 30.7 Thousand USD | 572.199% |
| Agentix Corp. | - USD | Infinity% |
| Resverlogix Corp. | - USD | Infinity% |
| Nuo Therapeutics, Inc. | 482.43 Thousand USD | 130.057% |
| MetaStat, Inc. | - USD | Infinity% |
| argenx SE | 1.1 Billion USD | 100.013% |
| Enzon Pharmaceuticals, Inc. | - USD | Infinity% |
| Endonovo Therapeutics, Inc. | -514.51 Thousand USD | 71.817% |
| RespireRx Pharmaceuticals Inc. | - USD | Infinity% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | - USD | Infinity% |
| AVAX Technologies, Inc. | 617.38 Thousand USD | 123.487% |
| Zenith Capital Corp. | - USD | Infinity% |
| Genscript Biotech Corporation | 409.55 Million USD | 100.035% |
| Ember Therapeutics, Inc. | - USD | Infinity% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -8856.00 USD | -1537.342% |
| WPD Pharmaceuticals Inc. | - USD | Infinity% |
| Cotinga Pharmaceuticals Inc. | -83.84 Thousand USD | -72.933% |
| Kadimastem Ltd | -630.13 Thousand USD | 76.989% |
| Helix BioMedix, Inc. | 987.98 Thousand USD | 114.677% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Reve Technologies, Inc. | - USD | Infinity% |
| LadRx Corporation | -11.83 Thousand USD | -1125.205% |
| Cell Source, Inc. | - USD | Infinity% |
| Regen BioPharma, Inc. | 176.56 Thousand USD | 182.127% |
| NovAccess Global Inc. | - USD | Infinity% |
| Affymax, Inc. | 1.35 Million USD | 110.684% |
| Itoco Inc. | - USD | Infinity% |
| Rasna Therapeutics, Inc. | - USD | Infinity% |
| Pathfinder Cell Therapy, Inc. | - USD | Infinity% |
| Mobile Lads Corp. | - USD | Infinity% |
| CytoDyn Inc. | -29 Thousand USD | -400.01% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | - USD | Infinity% |
| NanoSphere Health Sciences Inc. | - USD | Infinity% |
| Alseres Pharmaceuticals, Inc. | 450.04 Thousand USD | 132.22% |
| SYBLEU INC | 11.69 Thousand USD | 1339.766% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| ImmunoCellular Therapeutics, Ltd. | - USD | Infinity% |
| International Stem Cell Corporation | 4.6 Million USD | 103.147% |
| Bioxytran, Inc. | -8285.00 USD | -1650.187% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | - USD | Infinity% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | - USD | Infinity% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | - USD | Infinity% |
| Adhera Therapeutics, Inc. | - USD | Infinity% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | - USD | Infinity% |
| Innovation Pharmaceuticals Inc. | -373 Thousand USD | 61.125% |
| Neutra Corp. | 14.33 Thousand USD | 1111.531% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | -76.833% |
| PureTech Health plc | -1.6 Million USD | 90.954% |
| Coeptis Therapeutics, Inc. | -1 Million USD | 85.518% |
| IXICO plc | 3.27 Million USD | 104.434% |
| IntelGenx Technologies Corp. | -694 Thousand USD | 79.106% |
| Gelesis Holdings, Inc. | -1.79 Million USD | 91.904% |
| CSL Limited | 7.7 Billion USD | 100.002% |
| Cellectis S.A. | 18 Thousand USD | 905.572% |